Literature DB >> 22215931

Aldosterone and Risk for Insulin Resistance.

Adam Whaley-Connell1, James R Sowers.   

Abstract

Entities:  

Year:  2011        PMID： 22215931      PMCID： PMC3230820          DOI： 10.1161/HYPERTENSIONAHA.111.182782

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  10 in total

1.  Plasma aldosterone levels and development of insulin resistance: prospective study in a general population.

Authors:  Eita Kumagai; Hisashi Adachi; David R Jacobs; Yuji Hirai; Mika Enomoto; Ako Fukami; Maki Otsuka; Shun-ichi Kumagae; Yasuki Nanjo; Kuniko Yoshikawa; Eishi Esaki; Kanako Yokoi; Kinuka Ogata; Akiko Kasahara; Eri Tsukagawa; Kyoko Ohbu-Murayama; Tsutomu Imaizumi
Journal:  Hypertension       Date:  2011-11-07       Impact factor: 10.190

Review 2.  Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities.

Authors:  Lakshmi Pulakat; Vincent G DeMarco; Sivakumar Ardhanari; Anand Chockalingam; Rukhsana Gul; Adam Whaley-Connell; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-03       Impact factor: 3.619

3.  Comparisons for body mass index and body fat percent among Puerto Ricans, blacks, whites and Asians living in the New York City area.

Authors:  J Wang; J C Thornton; S Burastero; J Shen; S Tanenbaum; S B Heymsfield; R N Pierson
Journal:  Obes Res       Date:  1996-07

4.  Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

Authors:  Francesco Fallo; Franco Veglio; Chiara Bertello; Nicoletta Sonino; Paolo Della Mea; Mario Ermani; Franco Rabbia; Giovanni Federspil; Paolo Mulatero
Journal:  J Clin Endocrinol Metab       Date:  2005-11-15       Impact factor: 5.958

5.  New criteria for 'obesity disease' in Japan.

Authors: 
Journal:  Circ J       Date:  2002-11       Impact factor: 2.993

6.  Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.

Authors:  Gilberta Giacchetti; Vanessa Ronconi; Federica Turchi; Laura Agostinelli; Franco Mantero; Silvia Rilli; Marco Boscaro
Journal:  J Hypertens       Date:  2007-01       Impact factor: 4.844

7.  Insulin sensitivity in patients with primary aldosteronism: a follow-up study.

Authors:  Cristiana Catena; Roberta Lapenna; Sara Baroselli; Elisa Nadalini; Gianluca Colussi; Marileda Novello; Grazia Favret; Alessandra Melis; Alessandro Cavarape; Leonardo A Sechi
Journal:  J Clin Endocrinol Metab       Date:  2006-07-05       Impact factor: 5.958

8.  Plasma aldosterone is independently associated with the metabolic syndrome.

Authors:  Murielle Bochud; Jürg Nussberger; Pascal Bovet; Marc R Maillard; Robert C Elston; Fred Paccaud; Conrad Shamlaye; Michel Burnier
Journal:  Hypertension       Date:  2006-06-19       Impact factor: 10.190

Review 9.  Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.

Authors:  James R Sowers; Adam Whaley-Connell; Murray Epstein
Journal:  Ann Intern Med       Date:  2009-06-02       Impact factor: 25.391

10.  Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study.

Authors:  Erik Ingelsson; Michael J Pencina; Geoffrey H Tofler; Emelia J Benjamin; Katherine J Lanier; Paul F Jacques; Caroline S Fox; James B Meigs; Daniel Levy; Martin G Larson; Jacob Selhub; Ralph B D'Agostino; Thomas J Wang; Ramachandran S Vasan
Journal:  Circulation       Date:  2007-08-13       Impact factor: 29.690
  10 in total
  6 in total

1.  Diabetes mellitus and vascular disease.

Authors:  James R Sowers
Journal:  Hypertension       Date:  2013-05       Impact factor: 10.190

Review 2.  Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.

Authors:  Annayya R Aroor; Susan McKarns; Vincent G Demarco; Guanghong Jia; James R Sowers
Journal:  Metabolism       Date:  2013-08-08       Impact factor: 8.694

Review 3.  Oxidative stress in the cardiorenal metabolic syndrome.

Authors:  Adam Whaley-Connell; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

Review 4.  Perivascular adipose tissue as a regulator of vascular disease pathogenesis: identifying novel therapeutic targets.

Authors:  Ioannis Akoumianakis; Akansha Tarun; Charalambos Antoniades
Journal:  Br J Pharmacol       Date:  2016-12-14       Impact factor: 8.739

5.  Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation.

Authors:  Nathanne S Ferreira; Stêfany B A Cau; Marcondes A B Silva; Carla P Manzato; Fabíola L A C Mestriner; Takayuki Matsumoto; Fernando S Carneiro; Rita C Tostes
Journal:  Front Pharmacol       Date:  2015-03-02       Impact factor: 5.810

6.  Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.

Authors:  Awsan Noman; Karthik Balasubramaniam; M Hafez A Alhous; Kelvin Lee; Peter Jesudason; Muhammad Rashid; Mamas A Mamas; Azfar G Zaman
Journal:  Catheter Cardiovasc Interv       Date:  2016-12-28       Impact factor: 2.692
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.